BLOPEPBOLANG BIOTECHNOLOGY

GH-releasing factor analogue

Tesamorelin

Tesamorelin is a growth hormone releasing factor analogue studied in defined clinical populations, including people with HIV-associated abdominal adiposity.

BLOPEP vial — representative image
Representative image
Quantity per vial

Select variantCompare prices and choose a variant to set the quantity and add it to your quote.

Subtotal excludes freight and taxes. Availability and final terms are confirmed in the quote. Commercial and shipping terms

Mechanism and findings →

Mechanism and findings

Human study · Study formulation · 412 participants with HIV-associated abdominal fat accumulation

Visceral adipose tissue

A randomized placebo-controlled trial evaluated visceral fat by CT over 26 weeks in a specific clinical population.

Falutz et al., 2007 →

Literature findings; refer to the model and formulation studied.

Mechanism of action

Tesamorelin — gh-releasing factor analogue. The literature identity must be matched to the documented chemical form and composition of the supplied material.

GH-releasing factor signaling was investigated in a population with HIV and abdominal fat accumulation. The trial used CT to measure visceral adipose tissue and followed lipids and IGF-I. The specific population limits transfer of findings to other conditions.

  • GHRH/GH axis

Falutz et al., 2007

Studied findings 1
Human study · Study formulation

Visceral adipose tissue

412 participants with HIV-associated abdominal fat accumulation

A randomized placebo-controlled trial evaluated visceral fat by CT over 26 weeks in a specific clinical population.

View context
Study design
Original-study abstract; experimental design described in linked source
Sample scope / arm
Not extracted; consult original study
Comparator
See original-study context
Experimental context (not instructions for use)
Abstract-level extraction; full methods and tables still require review.
Source section / table / abstract
Abstract

Evidence concerns the studied material and model, not the supplied BLOPEP batch.

Falutz et al., 2007

Sources and studies 1
  1. Metabolic effects of a growth hormone-releasing factor in patients with HIV.

    Falutz J, Allas S, Blot K, Potvin D, Kotler D, Somero M, Berger D, Brown S, Richmond G, Fessel J, Turner R, Grinspoon S · 2007 · The New England journal of medicine

    DOI: 10.1056/nejmoa072375

Specifications and packaging

Nominal variant content; analytical results belong to the documented batch.

Material type
Peptide

Quality and analyses

Review specifications, analytical results and documentation for published batches.

Purity
>99%
Type
Declared specification

Published batches

Batch results have not yet been published on this page.

Look up batch

Storage

Consult the specific conditions in the supplied material documentation.

Delivery and commercial terms

Freight, timing and import terms will be confirmed in the quote for the selected destination.

Other materials in this area

View category →